TrialThe oncologist2019

Apatinib for Advanced Osteosarcoma after Failure of Standard Multimodal Therapy: An Open Label Phase II Clinical Trial.

Lu Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.